drugset
drugset / Trial / NCT03812198

A Trial to Investigate the Safety, Tolerability, and Drug Levels in Blood After Single and Multiple Doses of LEO 32731 in Healthy People

NCT03812198 ↗

Phase 1 Completed 66 enrolled LEO Pharma
RandomizedSequentialTriple-blindTreatment

Summary

This is a phase 1 trial to evaluate the safety, tolerability, and pharmacokinetics of 4 different oral formulations of LEO 32731 in healthy subjects. The trial will be conducted in 3 parts at a single site. Each eligible subject will be enrolled into 1 group only and will participate in 3 treatment periods.

Timeline

Start
2019-01-22
Primary completion
2019-06-13
Completion
2019-06-13

Drugs

EvaluationDrugModalityDoseRoute
Subject LEO 32731 Unknown — Oral

Indications

No indication recorded.